In this study, we undertook global tyrosine phosphorylation profiling of three GEM models of breast cancer: a HER2 model featuring expression of an activated form of the receptor lacking the extracellular domain [26], as well as the MMTV-PyMT and p53-null transplant models. This evidence concerns the gene ERBB2 and breast cancer.